Because of the common nature of non-alcoholic fatty liver disease and the chance of progression to non-alcoholic steatohepatitis, cirrhosis, and hepatocellular carcinoma, researchers sought to estimate the...
Previous research has indicated that use of sodium-glucose cotransporter-2 inhibitors could be associated with a rare urologic necrotizing infection. In a recent analysis, the FDA sought to further examine...
While metformin is the most common treatment of choice in children with type 2 diabetes, early loss of glycemic control has been observed with metformin monotherapy.
Although type 2 diabetes is the leading cause of kidney failure, few long-term treatment options for renoprotection in these patients are currently available.
While type 1 and type 2 diabetes in parents is already a well-established risk factor for diabetes in children, the authors of the new study sought to examine the impact of gestational diabetes mellitus on...
In a recent study, researchers sought to examine the relationship between age of diagnosis with type 2 diabetes mellitus and risk of mortality and cardiovascular disease.
The American Diabetes Association has updated its 2019 standards of care for diabetes focusing on the improvement of cardiovascular and renal health in individuals with diabetes.
In recognition of the rising prevalence of diabetes in the United States, especially among older adults, the Endocrine Society has published a new clinical practice guideline for the treatment of diabetes...
In a recent study, researchers sought to explore the effects of concomitant use of GLP-1 receptor agonists with SGLT-2 inhibitors in patients with poorly controlled type 2 diabetes.
In a recent study, researchers sought to estimate the long-term risk of cardiovascular disease based on fasting glucose levels that are below the threshold of diabetes.
